摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{(2S)-1-[(2S,4S)-2-{2'-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H,1'H-7,7'-binaphtho[1,2-d]imidazol-2-yl}-4-(methylsulfanyl)pyrrolidin-1-yl]-3-methyl-1-oxobutane-2-yl}carbamic acid methyl ester | 1377047-28-3

中文名称
——
中文别名
——
英文名称
{(2S)-1-[(2S,4S)-2-{2'-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H,1'H-7,7'-binaphtho[1,2-d]imidazol-2-yl}-4-(methylsulfanyl)pyrrolidin-1-yl]-3-methyl-1-oxobutane-2-yl}carbamic acid methyl ester
英文别名
methyl {(2S)-1-[(2S,4S)-2-{2'-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H,1'H-7,7'-binaphtho[1,2-d]imidazol-2-yl}-4-(methylsulfanyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(2S,4S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-4-methylsulfanylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
{(2S)-1-[(2S,4S)-2-{2'-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H,1'H-7,7'-binaphtho[1,2-d]imidazol-2-yl}-4-(methylsulfanyl)pyrrolidin-1-yl]-3-methyl-1-oxobutane-2-yl}carbamic acid methyl ester化学式
CAS
1377047-28-3
化学式
C45H52N8O6S
mdl
——
分子量
833.024
InChiKey
VAFAOXCFMLMWTK-FETRQNOVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.5
  • 重原子数:
    60
  • 可旋转键数:
    12
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    200
  • 氢给体数:
    4
  • 氢受体数:
    9

文献信息

  • ANTIVIRAL COMPOUNDS
    申请人:Bacon Elizabeth M.
    公开号:US20140018313A1
    公开(公告)日:2014-01-16
    The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及抗病毒化合物、含有这种化合物的组合物、包括给予这种化合物的治疗方法,以及用于制备这种化合物的有用过程和中间体。
  • Antiviral compounds
    申请人:GILEAD PHARMASSET LLC
    公开号:US10344019B2
    公开(公告)日:2019-07-09
    The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及抗病毒化合物、含有此类化合物的组合物、包括施用此类化合物的治疗方法,以及制备此类化合物的工艺和中间体。
  • US9156823B2
    申请人:——
    公开号:US9156823B2
    公开(公告)日:2015-10-13
  • [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
    申请人:GILEAD SCIENCES INC
    公开号:WO2012068234A2
    公开(公告)日:2012-05-24
    The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
查看更多